Michael Berk

107.2k total citations · 25 hit papers
1.4k papers, 68.2k citations indexed

About

Michael Berk is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Clinical Psychology. According to data from OpenAlex, Michael Berk has authored 1.4k papers receiving a total of 68.2k indexed citations (citations by other indexed papers that have themselves been cited), including 605 papers in Psychiatry and Mental health, 282 papers in Biological Psychiatry and 256 papers in Clinical Psychology. Recurrent topics in Michael Berk's work include Bipolar Disorder and Treatment (439 papers), Tryptophan and brain disorders (282 papers) and Schizophrenia research and treatment (220 papers). Michael Berk is often cited by papers focused on Bipolar Disorder and Treatment (439 papers), Tryptophan and brain disorders (282 papers) and Schizophrenia research and treatment (220 papers). Michael Berk collaborates with scholars based in Australia, United States and Brazil. Michael Berk's co-authors include Michaël Maes, Felice N. Jacka, Olivia Dean, Seetal Dodd, Julie A. Pasco, Gin S. Malhi, Lana J. Williams, Eduard Vieta, Gerwyn Morris and Adrienne O’Neil and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Michael Berk

1.3k papers receiving 66.4k citations

Hit Papers

Bipolar disorder 1991 2026 2002 2014 2015 2013 2010 2010 2008 250 500 750 1000

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael Berk 22.7k 15.9k 10.0k 9.4k 8.4k 1.4k 68.2k
Michaël Maes 14.2k 0.6× 28.4k 1.8× 4.7k 0.5× 9.8k 1.0× 7.3k 0.9× 1.0k 62.7k
Brenda W.J.H. Penninx 10.5k 0.5× 10.2k 0.6× 17.3k 1.7× 4.0k 0.4× 11.7k 1.4× 989 74.1k
Charles B. Nemeroff 10.3k 0.5× 14.7k 0.9× 15.8k 1.6× 11.1k 1.2× 5.6k 0.7× 974 77.0k
Roger S. McIntyre 15.6k 0.7× 8.7k 0.5× 12.9k 1.3× 2.8k 0.3× 4.0k 0.5× 1.0k 46.1k
J. John Mann 10.4k 0.5× 6.7k 0.4× 15.8k 1.6× 7.1k 0.8× 3.1k 0.4× 640 47.3k
John H. Krystal 11.3k 0.5× 11.8k 0.7× 11.5k 1.2× 7.8k 0.8× 3.4k 0.4× 651 60.2k
Maurizio Fava 17.1k 0.8× 11.9k 0.7× 10.9k 1.1× 3.7k 0.4× 3.6k 0.4× 932 59.7k
A. John Rush 24.2k 1.1× 10.9k 0.7× 17.8k 1.8× 13.6k 1.4× 3.2k 0.4× 914 87.4k
Carmine M. Pariante 6.5k 0.3× 12.7k 0.8× 8.1k 0.8× 3.8k 0.4× 2.7k 0.3× 495 38.0k
George P. Chrousos 6.2k 0.3× 6.7k 0.4× 7.6k 0.8× 11.4k 1.2× 15.4k 1.8× 1.4k 96.8k

Countries citing papers authored by Michael Berk

Since Specialization
Citations

This map shows the geographic impact of Michael Berk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Berk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Berk more than expected).

Fields of papers citing papers by Michael Berk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Berk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Berk. The network helps show where Michael Berk may publish in the future.

Co-authorship network of co-authors of Michael Berk

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Berk. A scholar is included among the top collaborators of Michael Berk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Berk. Michael Berk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Forbes, Malcolm, Duncan J. Topliss, Mojtaba Lotfaliany, et al.. (2025). Thyroid-Stimulating Hormone Levels and Depression in Older Adults: Cross-Sectional and Longitudinal Analyses in a Community-Dwelling Population. American Journal of Geriatric Psychiatry. 34(4). 544–554.
2.
Eratne, Dhamidhu, Olivia Dean, Michael Berk, et al.. (2025). Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Are Elevated in Bipolar Depression: Evidence for Neuroprogression and Astrogliosis. Bipolar Disorders. 27(5). 379–388. 2 indexed citations
3.
Salmerón, S., Marc Valentí, Michael Berk, et al.. (2025). Beyond Highs and Lows: Unraveling Cannabis Withdrawal‐Induced Mania—A Two‐Year Observational Study of Hospital Admissions From 2015 to 2019. Acta Psychiatrica Scandinavica. 152(3). 193–202.
4.
Aggarwal, Shilpa, Michael Berk, Nilesh Shah, et al.. (2025). Effectiveness of ATMAN psychological intervention in reducing self-harm in young people in India: a mixed method case series. Cambridge Prisms Global Mental Health. 12. e41–e41.
5.
McGuinness, Amelia J., Martin O’Hely, Douglas Stupart, et al.. (2024). Prior Appendicectomy and Gut Microbiota Re-Establishment in Adults after Bowel Preparation and Colonoscopy. Biomedicines. 12(9). 1938–1938.
6.
Giménez‐Palomo, Anna, Mojtaba Lotfaliany, Seetal Dodd, et al.. (2024). Efficacy and tolerability of monoamine oxidase inhibitors for the treatment of depressive episodes in mood disorders: A systematic review and network meta‐analysis. Acta Psychiatrica Scandinavica. 150(6). 500–515. 3 indexed citations
7.
Bernard, Jérémy, Ryad Tamouza, Ophélia Godin, et al.. (2024). Mitochondria at the crossroad of dysregulated inflammatory and metabolic processes in bipolar disorders. Brain Behavior and Immunity. 123. 456–465. 6 indexed citations
8.
Cotton, Sue, Simon Rice, Sarah Hetrick, et al.. (2024). Psychometric properties of the Bipolar Spectrum Diagnostic Scale in depressed youth. Journal of Affective Disorders. 372. 347–355.
9.
Skvarc, David, Mohammadreza Mohebbi, David Camfield, et al.. (2023). The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial. Clinical Psychopharmacology and Neuroscience. 21(2). 320–331. 2 indexed citations
10.
Kim, Hanjoo, Kelly A. Ryan, Scott A. Langenecker, et al.. (2023). Childhood trauma relates to worse memory functioning in bipolar disorder. Journal of Affective Disorders. 333. 377–383. 7 indexed citations
11.
O’Shea, Melissa, Hannah Capon, David Skvarc, et al.. (2022). A pragmatic preference trial of therapeutic yoga as an adjunct to group cognitive behaviour therapy versus group CBT alone for depression and anxiety. Journal of Affective Disorders. 307. 1–10. 7 indexed citations
12.
Wrobel, Anna, Mojtaba Lotfaliany, Alyna Turner, et al.. (2022). Attachment insecurity partially mediates the relationship between childhood trauma and depression severity in bipolar disorder. Acta Psychiatrica Scandinavica. 145(6). 591–603. 10 indexed citations
13.
Okechukwu, Chidiebere Emmanuel, Mark D. Griffiths, Mauro Giovanni Carta, et al.. (2022). Biological and practical considerations regarding circadian rhythm and mental health relationships among nurses working night shifts: a narrative review and recommendations. Rivista di psichiatria. 57(2). 67–79. 16 indexed citations
14.
Méndez, Raúl, Vicent Balanzá‐Martínez, Iris Estrada, et al.. (2021). Short‐term neuropsychiatric outcomes and quality of life in COVID‐19 survivors. Journal of Internal Medicine. 290(3). 621–631. 149 indexed citations breakdown →
15.
Raghu, Ganesh, Michael Berk, Peter A. Campochiaro, et al.. (2020). The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. Current Neuropharmacology. 19(8). 1202–1224. 190 indexed citations breakdown →
16.
Francey, Shona M., Barnaby Nelson, Susy Harrigan, et al.. (2012). Should antipsychotic medication always be given for first-episode psychosis?. Own your potential (DEAKIN). 2 indexed citations
17.
Lucena, David Freitas de, Brisa S. Fernandes, Michael Berk, et al.. (2009). Improvement of schizophrenia negative and positive symptoms with memantine as add-on therapy to clozapine: a double-blind, randomized, placebo-controlled trial. Deakin Research Online (Deakin University). 1 indexed citations
18.
Dodd, Susanna, et al.. (2008). Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics : a double-blind, randomised, placebo-controlled clinical trial. Deakin Research Online (Deakin University). 1 indexed citations
19.
Berk, Michael, et al.. (2006). Seasonal influences on first episode admission in affective and non-affective psychosis. Own your potential (DEAKIN). 1 indexed citations
20.
Buuse, Maarten van den, et al.. (2004). N-acetyl-cysteine treatment inhibits depletion of brain glutathione levels in rats : implications for schizophrenia. Deakin Research Online (Deakin University). 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026